Svipgerðarbreytingar í sortuæxlum og hlutverk umritunarþáttarins MITF
Year: 2026
Type: dissertation
Abstract: Melanoma cells undergo a process known as phenotype switching, a form of cellular plasticity where cells transition between a proliferative, differentiated state and an invasive, mesenchymal-like state. The master regulator of this process is the Microphthalmiaassociated transcription factor (MITF), which acts as a transcriptional rheostat and controls differentiation and invasion in melanoma. This study investigates the molecular mechanisms by which MITF regulates the expression of key epithelial, mesenchymal, and melanocytic genes. Crucially, this study identifies a specific intronic enhancer (CDH1-B) through which MITF directly activates transcription of the epithelial marker CDH1. This activation occurs independently of canonical EMT repressors (ZEB1, SNAI1, and TWIST1), establishing MITF as a primary driver of the differentiated epithelial state in melanoma. In contrast, while MITF loss leads to increased expression of the mesenchymal marker CDH2 and invasive phenotype marker SERPINA3, the results suggest that this regulation is mediated through indirect mechanisms. Further mapping of the MITF regulatory network revealed that MITF also binds to intronic enhancers to directly activate the melanocyte marker MLANA and the differentiation-promoting factor ZEB2, while its repression of pro-invasive EMT transcription factors remains largely indirect. To identify novel regulators of this network, a genome-wide CRISPR knockout (GeCKO) screen was performed using newly developed reporter cell lines. The screen identified a pool of upstream repressors that actively silence the CDH1 expression in both MITF-high and MITF-low conditions. Collectively, these findings show MITF as a central rheostat that maintains the differentiated state through direct activation of epithelial markers and indirect suppression of the invasive program, providing a foundation for identifying new therapeutic targets to prevent metastatic progression.
Source: Opin vísindi (Opin vísindi)
Author: Evangeline Breeta
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7203961492
